Home›Companies›Biotech & Pharma›Lucier Pharmaceuticals

Lucier Pharmaceuticals Inc.

Develops drug candidates for people with coronary microvascular dysfunction.

Updated Nov 9, 2026·Latest SEC filing Oct 13, 2026·Suggest an edit

About Lucier Pharmaceuticals

Lucier Pharmaceuticals is a private company based in Bryan, Texas, incorporated in 2023 in Texas. It has reported $0 raised in one offering on Form D since October 2026. Its chief executive is Guangrong Lu Lu.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetOct 13, 2026$0of $2.0M target3$0SAFE (Simple Agreement for Future Equity), which does not grant immediate equity or voting rights.Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Lucier Pharmaceuticals's Form D filed Oct 13, 2026.

Sources

  1. SECLUCIER PHARMACEUTICALS INC filing history
  2. CompanyPrivacy policy